WST
Ticker
West Pharmaceutical Services In
Company
Devices
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
4.6%7.9%6.2%8.1%3.9%-1.5%7.8%6.0%7.4%7.1%16.7%31.9%2.0%2.2%-1.9% 4.9%
Revenue Growth QoQ
Gross Margin
28.8%28.8%28.5%30.6%31.8%31.5%32.6%33.2%32.1%31.8%32.9%35.8%41.5%39.4%38.3%34.5% 35.6%
EBITDA Margin
15.7%14.8%15.5%16.7%18.1%19.1%15.6%19.1%20.2%20.1%21.7%24.0%30.9%29.6%27.6%25.1% 25.0%
Operating Margin
9.2%8.2%9.2%10.7%11.9%12.8%9.2%13.0%14.1%14.0%16.1%19.0%26.6%25.4%22.9%19.7% 19.5%
Profit Margin
6.9%5.9%6.3%6.4%8.2%8.9%6.8%9.5%9.4%12.0%13.1%16.1%23.4%20.3%20.1%17.0% 16.3%
FCF / EBITDA
18.1%39.4%18.3%26.1%26.1%26.0%37.0%17.1%41.1%53.4%60.2%57.8%37.8%51.4%51.0%38.1% 50.3%